Self-reported caffeine consumption miss-matched consumption measured by plasma levels of caffeine and its metabolites: results from two population-based studies

Nermine Laaboub,Setareh Ranjbar,Marie-Pierre F. Strippoli,Pedro Marques-Vidal,Sandrine Estoppey-Younes,Belen Ponte,Menno Pruijm,Bruno Vogt,Nicolas Ansermot,Séverine Crettol,Frederik Vandenberghe,Peter Vollenweider,Martin Preisig,Murielle Bochud,Chin B. EAP
DOI: https://doi.org/10.1007/s00394-024-03351-9
IF: 4.8646
2024-05-08
European Journal of Nutrition
Abstract:Importance and objective Self-reported caffeine consumption has been widely used in research while it may be subject to bias. We sought to investigate the associations between self-reported caffeine consumption and plasma levels of caffeine and its two main metabolites (paraxanthine and theophylline) in the community. Methods Data from two population-based studies (SKIPOGH1 and 2 ( N = 1246) and CoLaus|PsyCoLaus ( N = 4461)) conducted in Switzerland were used. Self-reported caffeine consumption was assessed using questionnaires. Plasma levels of caffeine and its metabolites were quantified by ultra-high performance liquid chromatography coupled to a tandem quadrupole mass spectrometer. Results In both studies, mean log plasma levels of caffeine and its two metabolites were over 6.48 (plasma levels = 652 ng/ml) when no caffeine consumption was reported. Subsequently, nonlinear associations between log plasma levels and self-reported caffeine consumption were observed in SKIPOGH, with a change of the slope at 3–5 cups of espresso per day in SKIPOGH1 but not SKIPOGH2. In CoLaus|PsyCoLaus, increased daily consumption of caffeinated beverages was associated with increased log plasma levels with a change of the slope at 3 cups. In both studies, declared caffeine consumption higher than 3–5 cups per day was not associated with higher plasma levels of caffeine and its metabolites. Conclusion Self-reports of no or low caffeine consumption and consumption of more than 3–5 cups of coffee should be interpreted with caution, with possible under- or over-estimation. Quantifying plasma levels of caffeine and its metabolites may contribute to a better estimation of caffeine intake.
nutrition & dietetics
What problem does this paper attempt to address?
The main purpose of this paper is to investigate the association between self-reported caffeine intake and the levels of caffeine and its two major metabolites (paraxanthine and theobromine) in the blood. The study explores this topic through two Swiss population-based studies—SKIPOGH and CoLaus|PsyCoLaus. ### Main Findings 1. **Issues with Self-Reported No or Low Caffeine Intake**: - Among participants who reported no caffeine intake (accounting for 7-12% of the sample), the levels of caffeine and its metabolites in the blood were still relatively high (exceeding 652 ng/mL). - This suggests that these participants may have underestimated their caffeine intake, whether intentionally or unintentionally. 2. **Uncertainty with High Caffeine Intake**: - When the reported caffeine intake exceeded 3-5 cups of coffee per day, the levels of caffeine and its metabolites in the blood did not significantly increase. - This phenomenon may be due to an overestimation of intake or because individuals with higher CYP1A2 activity can metabolize and clear caffeine and its metabolites more quickly. 3. **Nonlinear Association**: - In the SKIPOGH study, when the intake reached 3-5 cups of coffee per day, the association between the levels of caffeine and its metabolites in the blood and the reported intake became insignificant. - A similar nonlinear trend was observed in the CoLaus|PsyCoLaus study, although the threshold differed. ### Conclusion - Self-reported caffeine intake may be biased, especially for participants who claim no intake or very high intake. - Quantitative analysis of caffeine and its metabolites in the blood can serve as an objective indicator, helping to more accurately assess actual intake. - The study emphasizes the need for caution when relying on self-reported data for health effect research and highlights the importance of using biomarkers for validation. In summary, this paper reveals the discrepancies between self-reported caffeine intake and actual biomarker measurements, and underscores the need for more careful handling of self-reported data in related research.